LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 3.66 | 27.76 | 526 | 283 | 1.8526 | 1.4036 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 3.66 | 27.76 | 2 | 283 | 0.0070 | -0.5435 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 3.66 | 27.76 | 547 | 283 | 1.9265 | 1.4318 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 5.36 | 27.76 | 599 | 320 | 1.8698 | 1.3881 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 5.36 | 27.76 | 659 | 320 | 2.0571 | 1.4536 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 7.06 | 27.76 | 2 | 360 | 0.0056 | -0.5091 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 7.06 | 27.76 | 709 | 360 | 1.9694 | 1.4024 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 7.06 | 27.76 | 6 | 360 | 0.0167 | -0.3392 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 7.06 | 27.76 | 728 | 360 | 2.0222 | 1.4197 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 8.76 | 27.76 | 3 | 401 | 0.0075 | -0.4387 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 8.76 | 27.76 | 749 | 401 | 1.8672 | 1.3519 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 8.76 | 27.76 | 7 | 401 | 0.0175 | -0.3006 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 8.76 | 27.76 | 807 | 401 | 2.0118 | 1.3978 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 10.46 | 27.76 | 818 | 438 | 1.8648 | 1.3388 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 10.46 | 27.76 | 12 | 438 | 0.0274 | -0.1899 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 10.46 | 27.76 | 878 | 438 | 2.0016 | 1.3808 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.17 | 27.76 | 7 | 489 | 0.0143 | -0.2831 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.17 | 27.76 | 844 | 489 | 1.7257 | 1.2818 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.17 | 27.76 | 48 | 489 | 0.0981 | 0.1415 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 12.17 | 27.76 | 934 | 489 | 1.9097 | 1.3384 | MN20160318_Q01 | G04 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 13.87 | 27.76 | 93 | 604 | 0.1538 | 0.3126 | MN20160318_Q01 | E05 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 13.87 | 27.76 | 889 | 604 | 1.4701 | 1.1811 | MN20160318_Q01 | E05 |